Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

5.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Structure and Function of Platelets01:18

Structure and Function of Platelets

1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.0K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

2.6K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nectin-4 Expression in Muscle-Invasive Bladder Cancer Is Associated with Growth-Related and Inflammatory Signaling Pathways.

International journal of molecular sciences·2026
Same author

Topographical and stage-related expression of nectin-4 in prostate cancer.

Central European journal of urology·2026
Same author

Nectin-4 expression in clear cell renal cell carcinoma.

Scientific reports·2026
Same author

Penile fracture and concomitant severe urethral trauma-a case report and discussion of surgical approach.

The Canadian journal of urology·2026
Same author

Using explainable AI to identify disease-relevant and deep brain stimulation treatment-sensitive gait features in Parkinson's disease.

Journal of neuroengineering and rehabilitation·2026
Same author

Recurrence patterns in primary urethral carcinoma: Prognostic impact of inguinal and pelvic lymphadenectomy.

Urologic oncology·2026

Related Experiment Video

Updated: Jun 16, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

Thromboxane A2 or Activated Platelets Slightly Lower Fgf23 Expression in vitro.

Elena Kohm1, Steffen Rausch1, Julia Vogt1

  • 1Department of Physiology, University of Hohenheim, Stuttgart, Germany.

Kidney & Blood Pressure Research
|May 4, 2025
PubMed
Summary

Thromboxane A2 (TxA2) signaling suppresses Fibroblast Growth Factor 23 (FGF23) production in bone cells. This TxA2-dependent regulation of FGF23 synthesis is relevant for diseases involving platelet aggregation.

Keywords:
Myocardial infarctionThrombinThrombocytes

More Related Videos

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.1K
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.0K

Related Experiment Videos

Last Updated: Jun 16, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
10:10

Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells

Published on: October 27, 2009

18.1K
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.0K

Area of Science:

  • Endocrinology
  • Cardiovascular Biology
  • Bone Metabolism

Background:

  • Fibroblast Growth Factor 23 (FGF23) regulates phosphate and vitamin D metabolism.
  • Elevated FGF23 is observed in myocardial infarction, potentially linked to cardiac changes.
  • Thromboxane A2 (TxA2) is crucial for platelet aggregation in myocardial infarction and thrombosis.

Purpose of the Study:

  • To investigate if Thromboxane A2 (TxA2) regulates Fibroblast Growth Factor 23 (FGF23) production.
  • To explore the role of TxA2 signaling in FGF23 synthesis within bone cells.

Main Methods:

  • Experiments utilized rat UMR-106 and mouse MC3T3-E1 cells.
  • Cells were exposed to TxA2, its receptor agonists/antagonists, or co-incubated with human platelets.
  • FGF23 gene expression (qRT-PCR) and protein levels (ELISA) were analyzed.

Main Results:

  • TxA2 and its agonists significantly suppressed Fgf23 gene expression and FGF23 protein levels.
  • Suppression was blocked by the TxA2 receptor antagonist SQ29548.
  • Activated human platelets, but not resting platelets, reduced Fgf23 gene expression in UMR-106 cells.

Conclusions:

  • Thromboxane A2 (TxA2) signaling inhibits FGF23 production in osteoblast-like cells.
  • TxA2-mediated regulation of FGF23 synthesis may be significant in conditions with increased platelet aggregation.